Remedy Is Automating the Phone Calls Your Pharmacist Hates Making

The Macro: Pharmacies Are Stuck in 1997

I talk to founders in healthcare AI constantly, and the pattern is almost always the same. They pick a glamorous problem. Diagnostics. Drug discovery. Surgical planning. Genomics. These are exciting areas and they are also areas where the regulatory burden is crushing, the sales cycles are measured in years, and the incumbents have deep moats built on clinical validation data.

Then there are pharmacies. Nobody thinks pharmacies are exciting. They are not on the cover of Wired. VCs do not write breathless blog posts about the future of prescription refills. And that is exactly why the opportunity is real.

There are roughly 88,000 pharmacies in the United States. Most of them run on software that looks like it was designed during the Clinton administration. The daily workflow at a typical independent pharmacy involves an absurd number of phone calls. Patients calling about refill status. Staff calling patients about pickup reminders. Insurance companies calling about prior authorizations. Doctors’ offices calling about prescription changes. The phone never stops ringing.

The pharmacy management system market is dominated by a handful of legacy players. QS/1, PioneerRx, Liberty Software, and BestRx handle the core dispensing workflow. None of them do a particularly good job with the communication layer. There are some newer entrants like Nimble and Alto that have modernized the patient-facing experience, but those are mostly consumer apps, not tools for the pharmacy staff. The operational side, the back-office phone calls and fax management and insurance follow-ups, remains almost entirely manual.

This matters because pharmacist burnout is real and it is getting worse. The workload has increased while staffing has decreased. Pharmacists spend a disproportionate amount of their day on administrative tasks that do not require a doctorate in pharmacy to execute. Every minute a pharmacist spends on hold with an insurance company is a minute they are not counseling patients or catching drug interactions.

The Micro: Michigan and Brown Meet at the Pharmacy Counter

Remedy is building AI agents that handle prescription refills and the operational communication around them. The pitch is clean: reduce the workload on pharmacy staff, improve patient response times, and let pharmacists focus on clinical work instead of phone tag.

Nikhil Devaraj and Vishnu Sreenivasan are the founders. Nikhil comes from the University of Michigan and Vishnu from Brown. They are a two-person team out of Y Combinator’s Fall 2025 batch. The product is early and the website is minimal, which is not unusual for a healthcare startup that is likely doing most of its business development through direct outreach to pharmacy owners rather than inbound marketing.

The AI agent approach is the right one for this problem. Prescription refills follow a predictable pattern. Patient requests refill. System checks if refills remain. If yes, queue it. If no, contact prescriber. Notify patient when ready. There are edge cases, of course, but the core workflow is rules-based with enough natural language variation to benefit from AI rather than a simple IVR tree.

What I like about targeting pharmacies specifically is that the buyer is accessible. Independent pharmacy owners make purchasing decisions quickly compared to hospital systems or insurance companies. The contract values are smaller but the sales cycle is measured in days, not quarters. You can get to meaningful revenue without a 12-person enterprise sales team.

The competitive landscape is thin. Pharmabot and a few other startups have tried pharmacy automation, but none have gained significant traction. The legacy PMS vendors are not going to build this themselves because their business model depends on per-seat licensing, not per-interaction pricing. An AI agent that reduces headcount is a threat to their revenue model.

I want to know more about their integration story. Pharmacies are not going to rip out their existing management systems. Remedy needs to sit on top of QS/1 or PioneerRx and handle the communication layer without requiring a workflow change from the pharmacist. If they have that integration working, the product sells itself. If they do not, they are asking pharmacists to switch between two systems, and that is a non-starter.

The Verdict

I think Remedy picked the right market. Pharmacy operations are manual, the buyers are accessible, the regulatory risk is lower than clinical AI, and the incumbents are asleep. The question is execution speed.

At 30 days, I want to see how many pharmacies are running pilots. Even five would be meaningful for a two-person team. At 60 days, I want to know the call deflection rate. If the AI agent handles 60% or more of refill-related calls without human intervention, that is a compelling number for any pharmacy owner doing the math on their phone bill and staffing costs. At 90 days, the question is whether this is a point solution or a platform. Refills are the entry point, but insurance follow-ups, prior authorizations, and patient communication are all adjacent problems with the same buyer. The team that nails refills first gets to expand into all of them. Remedy is in a good position if they move fast enough.